Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.93 +0.03 (+3.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Gains from Sales and Divestitures (2011 - 2026)

Updated

Lineage Cell Therapeutics (LCTX) posted Gains from Sales and Divestitures of -$19,000 for Q2 2026.

Analysis

Lineage Cell Therapeutics (LCTX) Gains from Sales and Divestitures (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Lineage Cell Therapeutics was -$31,000; for FY2022, it came in at $11,000.

  • Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of -63.7% (FY2017 to FY2022).
  • In prior years, Lineage Cell Therapeutics' Gains from Sales and Divestitures was -$24,000 in FY2021, $20,000 in FY2020, -$273,000 in FY2019 and $105,000 in FY2018 (-94.0%).
  • The Q2 2026 figure stands as the lowest quarterly Gains from Sales and Divestitures since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lineage Cell Therapeutics 235.20 Mn 33.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19,000.00
Mar 31, 2026 -12,000.00
Dec 31, 2021 -29,000.00
Dec 31, 2020 -134,000.00
Sep 30, 2012 -1,451.00
Jun 30, 2012 -3,546.00
Sep 30, 2011 -6,502.00
API Access

Lineage Cell Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LCTX&period=max&api_key=YOUR_API_KEY